The AdvaMed Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed China Code” or “Code” – serves as a foundational charter for medical technology companies’ compliance programs and encourages the companies to adopt best practices in the ethics unique to their industry.  

AdvaMed has developed revisions to the China Code to reaffirm the medtech industry’s dedication to ethical and compliant partnerships with health care providers in China. The revisions address evolving compliance and legal standards and incorporate additional provisions on risk areas unique to medical technology companies in China. The revised China Code is effective on July 1, 2024. 

The revisions to the text and FAQs: 

• Provide clearer guidance prohibiting all cultural courtesy gifts to HCPs (e.g., gifts for a wedding, birth, anniversary) as well as a complete prohibition on the provision of non-educational branded items to HCPs; 
• Reiterate the important role company representatives play in the clinical setting (i.e., they provide technical support on the safe and effective use of medical technology) and outline the principles that apply to company representatives in the clinical setting; 
• Address virtual interactions, meetings, and programs; 
• Reiterate that interactions with bona fide sub-distributors and sub-dealers should be conducted pursuant to all legal and ethical principles. 

Available in: 

• English 

• Chinese

Additional resources and implementation tools for the China Code of Ethics can be found here.

Certification and Training 

For resources to develop your own Code of Ethics training program for your staff, please contact Quentin Roemer.